This inventor holds 7 USPTO granted patents and 15 published patent applications and 3 EPO patents. Top assignees: Hummingbird Bioscience Holdings Pte. Ltd., Hummingbird Bioscience Pte. Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 4 
3 out of 3 Years Active: 2020-2026
Title: Jerome Douglas Boyd-Kirkup: Innovator in Antigen-Binding Molecules
Introduction
Jerome Douglas Boyd-Kirkup is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. He holds a total of six patents, showcasing his innovative work in developing antigen-binding molecules.
Latest Patents
Among his latest patents are the VISTA antigen-binding molecules, which are disclosed along with nucleic acids and expression vectors encoding these molecules. Additionally, he has developed HER3 antigen-binding molecules, which also include nucleic acids and expression vectors, as well as compositions and methods utilizing these innovative molecules.
Career Highlights
Jerome has worked with notable companies such as Hummingbird Bioscience Holdings Pte. Ltd. and Hummingbird Bioscience Pte. Ltd. His work in these organizations has been instrumental in advancing research and development in the field of antigen-binding technologies.
Collaborations
He has collaborated with talented individuals in his field, including Piers Ingram and Dipti Thakkar, contributing to a dynamic and innovative research environment.
Conclusion
Jerome Douglas Boyd-Kirkup's work in developing antigen-binding molecules has made a significant impact in biotechnology. His patents and collaborations reflect his dedication to advancing scientific knowledge and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile